Late sign-ups boost numbers, improve Obamacare outlook
Still to be announced is what share of those 8 million enrollees were previously uninsured, and how many actually secured coverage by paying their first month’s premiums.
Still to be announced is what share of those 8 million enrollees were previously uninsured, and how many actually secured coverage by paying their first month’s premiums.
When Lawrence and Francis Beck planted six acres of hybrid corn on their Hamilton County farm almost eight decades ago, the father and son sowed the seeds of a family business that’s still growing despite widespread industry consolidation.
Mainstreet Property Group LLC plans to launch a new round of private placement fundraising on April 21 using a website run by Oregon-based CrowdStreet Inc. and a mix of traditional advertising in central Indiana.
WellPoint’s commanding market share gave it a whopping $129 million in profit from its risk-based insurance products in 2012. But in percentage terms, WellPoint was not at the top of the heap.
Documents show House Speaker Pro Tem Eric Turner earned nearly $8 million selling nursing homes in the last two years and stands to earn between $1 million and $2 million on projects now being developed, thanks in part to legislation he helped block this year.
StreetLinks, which sells real estate appraisal management services and software, will retain its brand name and remain headquartered in Indianapolis, according to the statement.
Two of the state's top Republican lawmakers said Tuesday that they would like to see the federal government sign off on an expansion of Medicaid through the state's health care plan for low-income residents.
The state has not raised the eligibility threshold for Indiana Medicaid, but the program enrolled 40,577 more Hoosiers in March than it did in the same month last year.
For consumers that get tax subsidies in the Obamacare exchanges, out-of-pocket premiums will remain steady even if insurers raise prices next year. But the subsidies could fall if insurers offer lower-cost plans.
Evansville officials had pushed the location covering nearly six city blocks as a key for downtown redevelopment. The center that could draw some 2,000 health care students.
A top Indiana lawmaker, his family and investors in their company risked losing millions in future profits if a proposed ban on construction of new nursing homes in Indiana had become law this year, an Associated Press review has found.
The back-loaded enrollment process for the Obamacare exchanges gives insurers far, far less information about their new customers than usual.
From this week’s historic data dump, I learned who the top 20 recipients of Medicare payments are in Indianapolis (hint: mostly labs, ambulances and eye surgeons). But the real takeaway is that meaningful price information about doctors is still a long way away.
Health insurers such as WellPoint Inc. that plan to hike prices on their Obamacare policies more than 10 percent in 2015 will have a much harder time than usual making their case to regulators.
WellPoint Inc. is leading companies that have poured $13.4 million into defeating a ballot initiative that would give California regulators the power to reject increases in health policy premiums.
Eli Lilly and Co.’s stock showed little change Tuesday morning in the wake of a federal court decision that saw jurors order the company to pay a massive damage award related to its Actos diabetes medicine.
The former owner of a central Indiana dental clinic being investigated for Medicaid fraud has been sentenced to two years in federal prison for not paying more than $850,000 in taxes.
Takeda Pharmaceutical Co. and Eli Lilly and Co. were ordered to pay a combined $9 billion after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.
Court win last week in a patent challenge to lung cancer drug Alimta pushed Lilly shares higher than they’ve ever been since April 2007. Since then, the company’s pipeline has produced more misfires than the villains in a James Bond movie
Another public stock offering by the West Lafayette-based drugmaker swells its war chest for cancer drug development to $225 million.